Paracetamol

N/A

Report date: 2026/04/08 20:02:35

Base Information

Drug NameParacetamol
Drug Alias NameNTM-004NTM-005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitorsProstanoid FP receptor antagonists
TargetsProstanoid FP receptorCyclooxygenase-2
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)acute influenzaHeadache +[18] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaPortugalTunisia +[10] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeumentum Inc
China Registration ClassN/A

Develop Information

Active CompaniesUnither Pharmaceuticals, FranceAl-Quds UniversityHaleon PLC +[15] 
Inactive CompaniesSandozThe University Of QueenslandUniversidade Nova De Lisboa +[4] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)acute influenzaHeadache +[15] 
Inactive IndicationsHypertensionGlomerulonephritis, MembranousCommon Cold

Other Information

ATC CodeN/A
Related LinksN/A